Tradestie Institutional Equity Comparison Engine

DCTH vs CRMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRMD Overall Edge

CRMD Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin while DCTH counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, DCTH trades at N/M Forward P/E with 5.2% operating margin (+70.7% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
DCTH N/M vs CRMD 49.0x Fwd P/E
Growth & Margin Winner CRMD
Op Margin 5.2% vs 41.0% ยท YoY +70.7% vs -47.7%
Momentum & Technical Winner DCTH
1Y +128.6% vs -56.2% ยท 52W Pos 80% vs 3%
Options & Structure Winner DCTH
BREAKOUT (43rd %ile IV) vs BREAKDOWN (25th %ile IV)
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DCTH +128.57% CRMD -56.16% Spread: +184.73 pp (DCTH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DCTH Revenue CRMD Revenue DCTH Op. Margin CRMD Op. Margin Margin Edge
FY2018 N/A $0M N/A -6250.4% CRMD
FY2019 N/A $0M N/A -7416.3% CRMD
FY2020 N/A $0M N/A -11378.4% CRMD
FY2021 $0M $0M -690.0% -15417.5% DCTH
FY2022 $0M $0M -1245.1% -46819.9% DCTH
FY2023 $0M N/A -1849.0% N/A DCTH
FY2024 $40M $40M -33.4% -51.4% DCTH
FY2025 $90M $310M 0.8% 48.2% CRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DCTH (3) vs CRMD (7)
Institutional Metric DCTH CRMD Criterion Row Winner
Market Capitalization Scale $743.8M $384.7M Larger Scale DCTH
Trailing P/E Ratio Valuation 133.6x 2.4x Lower Multiple CRMD
Forward P/E Ratio Valuation N/M 49.0x Lower Multiple CRMD
Revenue Growth (YoY) Growth +70.7% -47.7% Higher Growth DCTH
Operating Margin (TTM) Profitability 5.2% 41.0% Higher Margin CRMD
Net Profit Margin Profitability 6.0% 15.5% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency 5.4% 15.3% Higher ROE CRMD
52-Week Range Position Momentum 80% ($8โ€“$23) 3% ($5โ€“$13) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 1.63ฮฒ ยท 131% Vol 1.20ฮฒ ยท 107% Vol Lower Realized Risk CRMD
Unified Institutional Score Composite Signal 35.9 / 100 (SELL) 53.2 / 100 (HOLD) Higher Composite CRMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DCTH vs CRMD Buy Guide
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DCTH nor CRMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.